This project concerns a new strategy of detecting biological molecules that relies on competitive exchange interactions of an analyte with two-component molecular tethers attaching superparamagnetic microspheres (4 microns in diameter) to a sensor surface. The individual tethers consist of either double stranded DNA or antibody-antigen complex and are designed to selectively detect either specific ssDNA or antigenic proteins, respectively, in sensitive reagentless fashion. Performance of sensors was investigated using human cardiac troponin I, a serum heart attack marker, as an example of analytes of credible relevance to biomedical diagnostics.
Introduction
Detection of biological molecules in a fast, simple, sensitive and inexpensive manner is currently one of the most actively pursued topics of scientific inquiry in the analytical sciences. The qualitative and quantitative identification of such molecules is important in medicine, biology, forensics, and many other areas. Proteins and nucleic acids are of particular interest as disease markers. Current immunoassays are generally capable of quantifying a protein of interest in less than an hour (1) . Most DNA and RNA assays are capable of quantifying target sequences in similar times.
The most sensitive methods for detecting DNA involve a PCR workup, which, in theory, can amplify even a single molecule of DNA to detectable levels (2) . Unfortunately, PCR is a relatively slow process which requires significant quantities of reagents in order to amplify the target molecules. While these drawbacks can be lessened with miniaturization and microfluidics, the fundamental obstacles of multiple steps and involvement of several reagents are unavoidable when using PCR (3) (4) (5) (6) (7) (8) . Similar ideas have been also employed in specific DNA sensors. If high sensitivity is needed, microor nano-beads are often used to amplify the signal from a small number of molecules (9) (10) (11) . In this family of methods, a bead is labeled with a probe sequence complementary to the target. An additional oligonucleotide complementary to a second part of the target sequence is bound to either a bead or the surface to generate the signal or facilitate a separation step. This allows the target DNA to be separated from the bulk solution and to determine the concentration of the target sequence.
Finally, a number of reagentless DNA sensors have been developed that involve single-stranded DNA (ssDNA) bound to a surface (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . When complementary ssDNA is introduced, the two strands hybridize. The change in charge, mass, fluorescence, or electrochemical current observed is then measured and related to the analyte solution concentration. A similar method uses oligonucleotide labeled magnetic (or paramagnetic) particles to change the conductivity of a thin wire via the giant magnetoresistive effect (23, 24) . Some investigators have used indirect routes to measure DNA (and proteins), such as measuring a conductivity change or the reduction of current that passes through a pore as the molecule completely or partially blocks the pore (25) (26) (27) (28) (29) (30) (31) (32) (33) .
From the perspective of this work, perhaps the most interesting DNA sensor reported recently was developed independently by Heeger (34) and Sauer (35) .
An oligonucleotide that forms a hairpin loop is bound to the device surface. The reporter group (either a fluorescence tag or an electrochemical probe) is attached to the free end of the strand. While the hairpin loop is intact, the signal is in one state (quenched by a second dye in the fluorescence setup or near the electrode and thus available for electrode reactions in the case of the electrochemical probe). When an oligonucleotide complementary to the hairpin loop region (but with a greater complementary length) is introduced, the hairpin loop structure is broken, moving the tag away from the surface and generating a signal: either an increase of fluorescence, or a decrease of electrochemical current.
While there is great interest in detecting DNA in a sequence-specific fashion, there is even greater interest in detecting and quantifying specific proteins. In the majority of cases, an immunoassay is the method of choice for determining the concentration of proteins. Most currently used immunoassays fall into one of two broad categoriescompetitive and immunometric assays (1, 36) . In competitive assays a small quantity of antibody is used in order to limit the number of binding sites. The analyte antigen competes with trace quantities of labeled antigen, and the ratio of bound to free labeled antigen is measured and calibrated to the analyte antigen concentration. The principal advantage of competitive immunoassays is that only a single antibody binding site is required and so smaller proteins can be used as the antigen (1). Indeed, competitive assays are now principally used with analytes that are too small for immunometric assays, as competitive assays generally have a lower sensitivity and more problems with nonspecific protein binding interferences than immunometric assays (1).
In an immunometric assay, two antibodies are used and antigen is the limiting factor. Generally, one antibody is bound to a solid support to enable separation. The second is labeled to enable the antibody-antigen complex to be detected. When the antigen is added, the two antibodies bind to different sites or epitopes on the antigen molecules, forming a "sandwich." The antibody-antigen complex is separated from any unbound antibodies after an incubation period, and the labeled antibody is used to determine the antigen concentration. This is often done by the use of enzymes (in ELISA), although fluorescence, isotope decay (IRMA), and even visual inspection can also be used. Immunometric assays have some substantial advantages over competitive assays, most importantly, a greater sensitivity. Also, since two antibody-antigen binding events are required to generate a signal, reduced interference from nonspecific protein binding is another advantage (1) . There are also some drawbacks to immunometric assays. In particular, finding two antibodies that bind with good specificity and selectivity at different epitopes can be a challenge or even impossible in cases of smaller analytes (42) (43) (44) . Also, at high antigen concentrations, the signal response to increasing antigen concentration is nonlinear and can even go down as capture antibody and label antibody are saturated with the excess of antigen, resulting in antigen and label antibody being lost in the separation step. This is known as the "hook effect" as the signal/antigen concentration curve hooks down at high antigen concentrations (45) .
Whether a competitive or immunometric assay is employed, most immunoassay setups require a dedicated lab, with large instruments and often with substantial sample workup and reagent requirements (1, 36) . Only a single analyte can be measured at a time with most instruments, and an individual run can take up to an hour, making the time and cost required to run a large volume of immunoassays significant. Despite difficulties related to antibody instability and other constraints of immunoassay, some progress has been made in developing simpler to operate, disposable test kits. Home pregnancy tests are a common example of simple, portable sandwich immunoassays easily performed outside of a lab. More generally, a diagnostic system developed by Abbott Point of Care Inc. (formerly I-STAT Corp.) allows an untrained user to perform several immunoassays and other tests on whole blood, including cardiotroponin I, BNP, and clinically relevant electrolytes. Currently, clinically relevant concentrations of various heart attack markers such as cardiotroponin I and BNP can be measured in less than twenty minutes (46) .
DNA and Immunogenic Protein Sensors
The approach in our sensor design relies on competitive exchange equilibria involving DNA or antibody-antigen complexes. Figure 1 illustrates the key elements of the DNA sensor design. The left hand side of the figure shows several micro-beads attached to the device surface via a number of dsDNA tethers. Each tether consists of a ssDNA fragment attached to the device surface (the surface-DNA) and a shorter, complementary ssDNA bound to the micro-bead surface (the bead-DNA). Hybridization of these two oligonucleotides during the initial sedimentation of micro-beads results in micro-bead attachment to the sensor surface. In addition, the surface-DNA is selected to also be complementary to the target DNA. When a sensor constructed this way is exposed to a small (sub-microliter) volume of analyte solution containing the target-DNA, the latter engages in a competitive exchange with the surface-DNA•bead-DNA complex constituting a tether:
This exchange is rendered favorable by a larger complementarity region within the surface-DNA•target-DNA complex relative to the surface-DNA•bead-DNA complex, functioning as an individual tether. The exchange results in the breaking of the tethers and a release of micro-beads as shown schematically on the right hand side of Figure 1 .
In addition to the selectivity intrinsic to the DNA hybridization and competitive exchange processes, we expect this design to embody three additional important features worth mentioning. 1. The beads are superparamagnetic, thus their release in a small external magnetic field of a massively parallel magnetic tweezers apparatus (see Experimental Section) can be easily followed with the aid of an optical microscope and constitutes the sensor's signal transduction mechanism. 2. This signal transduction also offers significant signal amplification and high sensitivity. In principle, if each microbead were attached with a single DNA tether, a single molecule event of equation [1] results in the release of a micro-bead, an easily detectable signal. 3. Since the competitive DNA exchange equilibria are rendered essentially irreversible by properly selecting surface-DNA, each target-DNA molecule is captured as it diffuses into the active region of the sensor and exchanges with the DNA of the tethers. In other words, the sensor acts as an integrating device. In a limit of low analyte concentrations, the sensor response (number of released micro-beads) becomes time dependent. As the concentration of target-DNA in the analyte sample decreases, the time delay between the introduction of an analyte and micro-bead release increases, reflecting diffusion of analyte DNA molecules to the sensor's reaction centers of the individual micro-beads. The functioning of a protein sensor is analogous, but involves one important modification. Bead attachment involves antibody-antigen (Ab-Ag) tethers as shown in Figure 2 . The antigenic protein used to form the tethers (Ag bead ) is the same protein as the one to be detected in an analyte solution (Ag analyte ). The pertinent exchange equilibrium underlying this sensor's operation can be written as:
Ab-Ag bead + Ag analyte ∅ Ab-Ag analyte + Ag bead [2] It is apparent that this reaction lacks any driving force; the Gibbs free energy of the competitive exchange is close to zero and thus the equilibrium constant, K, of reaction [2] is K=1. This is contradictory to the premise of the sensor functioning outlined above and must be overcome. To accomplish this, we apply a small force (F) directed to stretch the antibody-antigen tethers using the magnetic tweezers device as shown in Figure 2 . This, according to Bell's theory (47) , exponentially increases the dissociation rate constant k off (F) relative to its value in the absence of the force: 
where x is the distance over which the force acts on the Ab-Ag complex as it is gradually stretched. This, in turn, decreases the binding constant of the affected antigen by its antibody, K binding :
Since the equilibrium constant of reaction [2] can be expressed by the ratio of the binding constants, it is apparent that K>1 in the presence of a small magnetic force. In fact it is easy to show that in order to increase K from 1 to ca. 100 and thus to render reaction [2] to be nearly irreversible, we need to apply a force of ca 20-50 pN. Following the exchange and the breaking of the tether, the bead is released (right circle). The analyte antigen is engaged in a stronger Ab-Ag complex unaffected by the external force.
Experimental Section
A three cartridge Millipore water purification system provided nanopure water. Mono-and dibasic sodium phosphate, hydrogen peroxide (30%), sodium chloride, and glass microscope slides (precleaned) were obtained from Fisher. Tris hydrochloride (Ultra) was purchased from MP Biomedicals. Sulfuric acid (concentrated) and sodium citrate were obtained from EMD. Bovine serum albumin (BSA) was obtained from Sigma. Protein stabilization solution (PSS), a proprietary mixture consisting principally of lactitol, tris, and DEA-dextran with other chemicals in small quantities, was manufactured by Applied Enzyme Technology Ltd and was provided by Abbott Point of Care Inc., a division of Abbott Laboratories. Cardiac troponin ITC complex (troponin, or cardiotroponin) and polyclonal mouse antibodies to cardiotroponin were also provided by Abbott Point of Care Inc.. Dynabeads M-450 tosylated magnetic microbeads (4.5 µm diameter) were purchased from Invitrogen. Parafilm "M" was obtained from Pechiney plastic packaging. Aldehyde slides (Nexterion Slide AL) were purchased from Schott. Amicon Ultra centrifuge filter devices with a molecular weight cutoff of 10,000 Da were supplied by Millipore. 10 mL size exclusion desalting columns were supplied by BioRad.
Antibody was usually bound to the surface and cardiotroponin (antigen) to the bead, as illustrated in Figure 3 . The antibody and cardiotroponin were supplied in stabilizing solutions in small volumes (~200 µL) at relatively high concentrations (1-50 µg/mL), so they were first purified in size exclusion columns. In order to minimize protein loss due to interactions with container walls, an excess of BSA (50 mL of 6 mg/mL solution) was added with the protein. The protein was collected in centrifuge filter devices and concentrated in a centrifuge. Circular wells (ca 4 mm in diameter) for magnetic forceinduced detachment experiments were made on slides by melting precut parafilm onto the slide at ca 100° C. For injection runs, elongated tear-drop shaped wells were used in order to minimize bead loss to convective currents during injections.
To bind the antibodies to the slide, aldehyde slides were treated with an antibody solution for at least five hours (up to overnight). Subsequently, the slide was rinsed with PBS. 2 µL of 25% (by mass) PSS solution was then added to each circular well and 3 µL of 25% PSS solution was added to each elongated well. The solution was then dried, resulting in a final concentration of 2.5 mg solids/cm 2 .
Tosylated dynabeads were treated with cardiotroponin by washing a 50 µL aliquot of beads, resuspending it in 500 µL PBS, and then adding 50 µL of concentrated cardiotroponin solution (~300 ng/mL). The beads were rotated for 24 hours and then 50 µL of 6 mg/mL BSA and 0.1 M tris were added and the solution was mixed for another 24 hours. The treated beads were washed with PBS and then resuspended in a 25% PSS solution for storage. They could be refrigerated in this solution for up to two weeks. When the beads were to be used, an aliquot was diluted to 1-2 % PSS. To form the tethers, 3-5 µL of bead solution were added to the slides (which were coated with dried PSS) and the slides were again dried. At this point, the slides could be kept dessicated for up to two days. To do experiments, the spots were rehydrated using deionized water, as appropriate buffer was dried with the PSS.
In all runs, the tethered beads were imaged with a Nikon TE 2000-S inverted microscope using a Photometrix CoolSnap HQ2 camera and a Nikon Intensilight C-HGFI light source. The camera was controlled and the images were analyzed using NIS Elements 2.3 image acquisition and analysis software. A Newport M460A three directional translation stage was used to position a stack of 5 N52 grade neodymium rare earth disc magnets, each of which was 0.2 cm thick and 0.9 cm in diameter, obtained from K&J Magnetics, Inc.
During force runs, the number of beads in the circular well (several hundred to a few thousand beads were present initially) was tracked as the stack of magnets exerted a 5 pN, 25 pN, or 90 pN force on the beads. The force-distance calibration curve of the stack of magnets with dynabeads and the method used to obtain it has been discussed elsewhere (48) .
Injection runs were performed in elongated wells, with the beads tethered at the wide end of the well. After the device was rehydrated, a 5 pN force was applied for 2 minutes to remove any untethered beads. The analyte-containing solution was then introduced at the narrow end of the well. This produced a flow at the bead populated area that was reduced by around an order of magnitude relative to that observed when a simple circular well was used with a similar volume of solution added. The transport of the analyte solution to the bead region occurred quickly (within a second) (48) .
Results and Discussion
In this section we narrowly focus on the preliminary results illustrating the performance of a protein sensor designed to respond to human cardiac troponin I. Troponin is involved in the calcium ion mediated regulation of muscle contraction, along with actin and tropomyosin (49, 50) . Troponin has three subunits, the calcium binding C subunit, the tropomyosin-binding T subunit, and the inhibitory I subunit, and is often abbreviated as simply ITC. While the C subunit is identical in both cardiac and skeletal muscle, the I and T subunits differ sufficiently to develop specific antibodies (51) . The presence of cardiotroponin in serum has been shown to be a marker for myocardial injury (heart attack). Therefore, the detection of the cardiotroponin I or T subunit is the current method of choice for the diagnosis of this medical condition (46) . Attachment of superparamagnetic micro-beads to glass slides relied on antibodyantigen tethers as outlined in Figure 2 and 3. Troponin antibodies were covalently bound to aldehyde slides using dilute solutions of the antibody in BSA. In order to control the number of antibodies bound to the surface, the concentration of antibodies in the solution was reduced while the BSA concentration was held constant. Reducing the number of antibodies on the surface also reduced the number of tethers holding the beads to the surface. Troponin was bound to the micro-bead surface as outlined in the Experimental Section and illustrated in Figure 3 . Subsequently, an aliquot of micro-bead suspension was delivered to the sensor surface and the beads were allowed to sediment. At that point, we investigated the extent to which Ab-Ag tethers did form and were capable of attaching the micro-beads. We were also asking whether our procedures designed to limit attachment of micro-beads to the sensor surface via non-specific interactions (see Experimental Section) were successful. To answer these questions, a typical experiment involved application of a magnetically induced force of a specific magnitude to a population of micro-beads residing on the sensor surface, followed by optical monitoring the decrease of the bead population with time. Clearly, a successful Ab-Ag tether formation would be concluded if we observed a large fraction of the micro-beads remaining on the surface despite application of a force of 5 pN or greater. It is well known that a force of ca 5 pN is sufficient to lift a micro-bead such as those used in this work that are not surface bound other than through van der Waals interactions (52) . Conversely, we would like to see a large fraction of micro-beads being lifted off the surface in blank experiments in which no Ab-Ag tethers could form. Unfortunately, we found the problem of non-specific binding to be severe and difficult to control fully (48). We do not devote much space to this problem here as this part of our research will be the subject of a separate report. Figure 5 shows the fraction of the initial number of micro-beads remaining on the sensor surface (FBRS) as a function of time in a run during which a force of 5 pN, 25 pN, and 90 pN was applied at 1 s, 200 s, and 400 s, respectively. The top data set (red circles) represents the antibody-cardiotroponin tether system. Approximately 60% of the beads in this run remain attached over 200 s when 5 pN was acting on them. A slow decrease of FBRS to ca 42% and 30% following the application of the greater forces reflects gradual breaking of the Ab-Ag tethers. This is consistent with a typical strength of antibody-antigen interactions (52) . It also suggests that the number of tethers attaching individual beads is relatively low. We can only crudely estimate that number to be between 5 and 50. This estimate is supported by other experiments in which significantly larger numbers of tethers were formed when the antibody solution used in the Ab surface binding experiments was not diluted (48) . In those cases, the tether density was high enough so that the applied force applied was insufficient to remove the majority of the beads from the surface. This suggested that the 50 µ µ µ µm 50 µ µ µ µm number of tethers was of such a magnitude that a 90 pN force when spread over the existing tethers was insufficient to even sequentially break the tethers and release beads.
The other two sets of data in Figure 5 correspond to two different blank experiments. In those cases FBRS is ca 30 -40% and does not appreciably decrease with the increasing force. This behavior is consistent with covalent, non-specific binding of the micro-beads to the sensor surface. Indeed, in the limit of a high force and long times, FBRS in the first set of data corresponding to the Ab-Ag tethered beads reaches the same common limit of ca 30-35% indicating that about half of this bead population was attached via difficult to control, non-specific binding. Figure 5 . The fraction of the beads remaining on the surface (FBRS) as a function of time with an antibody-cardiotroponin tether system (red -top data set) compared to a run in which the surface is coated with antibodies and the beads with streptavidin (bluebottom data set) and when BSA coated the sensor surface and troponin coated the beads (purple -middle data set). At t = 1 s, a 5 pN force was applied, which was increased to 25 pN at t = 200 and to 90 pN at t = 400 s. The initial number of the beads was ca 500. FBRS is normalized to that initial number of beads.
While determining the number of tethers and the mechanism by which these tethers break is certainly important, the crucial experiment in testing the performance of this device involves addition of free antigen capable of engaging in a competitive exchange with Ag-Ab tethers as illustrated by equation 2 and Figure 2 . Typical results of such an experiment are shown in Figure 6 . During the first 200 s of this experiment, we followed the protocol of the experiment in Figure 5 . Subsequently, a small amount of free cardiotroponin (4.8 x 10 -16 moles, resulting in a final concentration of around 16 pM) was added to a device in which the beads were attached with a similar, small number of AbAg tethers as in the case of the device featured in Figure 5 . The mere act of this addition of a 10 µL aliquot of the antigen solution results in detachment of a fraction of beads. The remaining population at ca 202 s is rescaled to FBRS = 1.0 As can be seen in Figure  6 , some 70 s following the cardiotroponin addition, some beads began to be released. FBRS decreased to ca. 0.93 in about 170 s following cardiotroponin addition. There are a number of notable features of this set of data. First, the beads were released at a force of only 5 pN. Knowing that equilibrium [2] is not effective in breaking tethers in the absence of the external force, this result implies either a long distance over which the Time (s)
FBRS
force was applied (eqn. 3) or a greater sensitivity to force than expected. Either case is plausible -while antibodies have a shallow binding pocket, a force could deform the extended structure of an antibody, thus increasing the distance over which it is applied. Additionally, knowing the time after the injection at which the beads are released provides an upper bound of the number of tethers holding those beads to the surface. This is obtained by assuming that the reaction of the cardiotroponin with its antibody is diffusion limited. Figure 6 . The fraction of beads remaining on the surface (FBRS) when 10 µL of 1.05 ng/mL cardiotroponin solution (red -lower data set) or 10 µL 1.0 mg/mL BSA solution (blue -upper data set) was added to beads with a low number of antibodycardiotroponin tethers (similar to the experiment in Figure 5 ). The injection took place at t = 200 s with a 5 pN force acting on the beads. The data are normalized to the number of beads left after some beads were convectively removed. The experiments were performed in PBS.
As the bound antibody is spread over the entire surface, the diffusion of cardiotroponin to the surface (and to the beads) is expected to obey linear diffusion. Thus, an integrated flux of antigen, N(t), obtained by solving standard diffusion equations can be used as the total amount of cardiotroponin that reached the device surface over a given time: [5] ( ) Time (s)
Assuming the diffusion constant, D o , of cardiotroponin to be 1 x 10 -6 cm 2 /s, the area A to be the area under a single bead, and using the known initial antigen concentration C o (16 pM), around 100 cardiotroponin molecules arrived at the bead during 150 s (see Figure 6) . Therefore, the maximum number of tethers that could be broken is 100. While this is a relatively large number, it should be treated as an upper bound. In fact, the actual number of tethers is likely very much lower. This is because in the current sensor setup there are a number of factors working to slow the arrival of analyte molecules to the beads. First, the beads themselves hinder diffusion, forcing analyte molecules to diffuse around them. Additionally, there is a large quantity of antibody molecules bound to the device surface that are not involved in tether formation. These will bind to the cardiotroponin molecules as readily as antibody molecules involved in tethers, but with no restriction to diffusion processes. Thus, the free antibodies on the device surface, which act to sequester the added antigen, must be expected to significantly delay the bead release.
The sensor model outlined in Introduction suggests that the device should exhibit a response proportional to the analyte concentration. Efforts were made to construct a dose-response curve. However, due to difficulties with reproducibly fabricating devices, the sensor was only determined to possess a present/not present type response, with a sensitivity of at least 16 pM and an integration time of around 3 minutes. While this sensitivity is already comparable to the currently established immunoassay techniques, numerous possibilities exist to further, substantially increase the sensitivity of our sensor. Specifically, selective deactivation of the antibodies not involved in tether formation would eliminate a large sink of antigen. Knowing that only a very small fraction of the surface bound antibodies is involved in bead attachment, this could increase the device sensitivity by orders of magnitude.
Conclusions
A new class of sensing devices for biological molecules has been described. These sensors rely on the release of tethered beads through competitive exchange reactions. If the analyte is present, the tethers holding the beads to the surface are broken and the beads are released. The use of superparamagnetic beads and of magnetic tweezers apparatus allows a small force to be applied to the tethers, providing a driving force for the competitive exchange reaction. Additionally, the force serves to rapidly remove the untethered beads from the surface. This functions as a signal transduction mode that also brings about a considerable intrinsic amplification factor. A sensor was developed using a cardiotroponin-anticardiotroponin system. In the preliminary set of data, we achieved sensor's sensitivity of 16 pM for cardiotroponin using BSA solutions as a blank, which generated no response.
